South Korea’s ability to quickly manufacture and distribute diagnostics has been an important factor in controlling the spread of COVID-19 within the country, the US Food and Drug Administration says in a new report.
The 25 May document explains that the agency began looking into the South Korean approach in April 2020 after...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?